1-3 of 3
Sze Pui Tsui, MSc
Close
Sort by
Journal Articles

A Phase II Single-Arm Open-Labeled Study Evaluating Combination of Quizartinib and Omacetaxine Mepesuccinate (QUIZOM) in Newly Diagnosed or Relapsed/Refractory AML Carrying FlT3-ITD

Chunxiao Zhang, Garret MK Leung, MBBS, Sze Pui Tsui, MSc, Ho-Wan Ip, MBBS,FRCPA, Edmond S. K. Ma, MD, Chun Hang Au, PhD, Chris T.L. Chan, PhD, Ka Lam Nelson Ng, PhD, Sze Fai Yip, MD, Bonnie Kho, MD, Harold K K Lee, MD, Qing LIU, Thomas Wing Yan Leung, Yok Lam Kwong, MD FRCP, Anskar Yu Hung Leung, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3825.
https://doi.org/10.1182/blood-2019-126510
Published: 2019
Journal Articles

A Mutation Pentad Defined Outcome of De Novo and Cytogenetically Normal Acute Myeloid Leukaemia in Young Adults

Sze Pui Tsui, MSc, Ip HW Alvin, Chunxiao Zhang, Tommy W.F. Tang, CH Lin, Arthur Cheung, Grace Cheng, Jason Chi Chiu So, FRCPath,MBBS, S.Y. Leung, Tommy CH Au, Edmond S. K. Ma, MD, Chris T.L. Chan, PhD, Margaret Ng, Kelvin CK Cheng, Kit Fai Wong, MBBS, MD FRCP, FRCPath, Lisa L.P. Siu, Sze Fai Yip, MD, S.Y. Lin, Szeman June Lau, T.H. Luk, Harold K K Lee, MD, Chi Kuen Lau, FRCP, Bonnie Kho, MD, Yok Lam Kwong, MD FRCP, Asif Javed, Anskar Yu Hung Leung, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1400.
https://doi.org/10.1182/blood-2019-130810
Published: 2019
Journal Articles

Characterization of Genomic Landscape and Risk Stratification of De Novo Cytogenetically Normal Acute Myeloid Leukaemia

Sze Pui Tsui, MSc, Tommy W.F. Tang, Ho-Wan Ip, MBBS, FRCPA, Jason Chi Chiu So, FRCPath, MBBS, Chun Hang Au, PhD, Edmond S. K. Ma, MD, Chris TL Chan, Margaret Ng, Kelvin C K Cheng, Kit Fai Wong, MBBS, MD FRCP, FRCPath, Lisa L.P. Siu, Sze Fai Yip, Sy Lin, Szeman June Lau, T.H. Luk, Harold K K Lee, Chi Kuen Lau, FRCP, Bonnie Kho, Chunxiao Zhang, Yok Lam Kwong, MD FRCP, Anskar Y.-H. Leung, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5267.
https://doi.org/10.1182/blood-2018-99-118909
Published: 2018